Radiologists, primary users of non-cardiac ultrasound

November 1, 2011 in Cancer

Although non-radiologist physicians have contributed to the widespread use of point-of-care (POC) ultrasound, radiologists remain the primary users, according to a study in the November issue of the Journal of the American College of Radiology. POC ultrasound is defined as an ultrasound performed (and interpreted) by the clinician at the bedside.

A recent paper in the by Moore and Copel indicated that miniaturization and a drop in costs have facilitated the growth of non-cardiac POC by and that the concept of an "ultrasound " is rapidly moving from the theoretical to a reality.

"The commentary by Moore and Copel raises the question of how widespread the use of non-cardiac ultrasound has become among non-radiologist physicians and how quickly such use is growing with the advent of hand-carried ultrasound devices. We used a nationwide database to investigate these questions," said David C. Levin, MD, lead author of the study.

To determine the rate of utilization of non-cardiac ultrasound by and other specialists, researchers at Thomas Jefferson University looked at Medicare Part B databases for 2004 to 2009. Between 2004 and 2009, there was a 21 percent increase in the overall utilization rate of non-cardiac ultrasound. POC ultrasound by non-radiologists amounted to 41 percent of all studies done in 2009, while radiologists performed 55 percent. Multiple non-radiologic specialties are involved, but radiologists' involvement is far higher than any other single specialty.

"The role of radiologists in non-cardiac ultrasound remains quite strong; however progressive miniaturization of ultrasound equipment may change that. As a result, utilization trends will require further watching and additional research in the coming years," said Levin.

More information: www.jacr.org/

Provided by American College of Radiology

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

ASCO: combo antibody therapy effective for melanoma

(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...

Cancer created 13 hours ago | popularity not rated yet | comments 0

Risk factors ID'd for poor cutaneous cell CA outcomes

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...

Cancer created 13 hours ago | popularity not rated yet | comments 0 | with audio podcast

Physical & emotional impairments common, often untreated in people with cancer

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvar ...

Cancer created 18 hours ago | popularity not rated yet | comments 0

Calif. doc with 'cancer cure' gets 14 years prison (Update)

(AP)—A California doctor has been sentenced to 14 years in federal prison for bilking her patients out of more than $1 million by promising that an herbal supplement could cure late-stage cancer and other diseases.

Cancer created 18 hours ago | popularity not rated yet | comments 0

New protein-targeting drug shows promise in early trial for patients with high-risk CLL

A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...

Cancer created 20 hours ago | popularity not rated yet | comments 0 | with audio podcast


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...